» Articles » PMID: 36012351

Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson's Disease

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Aug 26
PMID 36012351
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of Hemoglobin (Hb) is not restricted to erythrocytes but is also present in neurons. Hb is selectively enriched in vulnerable mesencephalic dopaminergic neurons of Parkinson's disease (PD) instead of resistant neurons. Controversial results of neuronal Hb levels have been reported in postmortem brains of PD patients: although neuronal Hb levels may decline in PD patients, elderly men with higher Hb levels have an increased risk of developing PD. α-synuclein, a key protein involved in PD pathology, interacts directly with Hb protein and forms complexes in erythrocytes and brains of monkeys and humans. These complexes increase in erythrocytes and striatal cytoplasm, while they decrease in striatal mitochondria with aging. Besides, the colocalization of serine 129-phosphorylated (Pser129) α-synuclein and Hb β chains have been found in the brains of PD patients. Several underlying molecular mechanisms involving mitochondrial homeostasis, α-synuclein accumulation, iron metabolism, and hormone-regulated signaling pathways have been investigated to assess the relationship between neuronal Hb and PD development. The formation of fibrils with neuronal Hb in various neurodegenerative diseases may indicate a common fibrillization pathway and a widespread target that could be applied in neurodegeneration therapy.

Citing Articles

The association between methylmalonic acid, a biomarker of mitochondrial dysfunction, and cause-specific mortality in Alzheimer's disease and Parkinson's disease.

Zhan F, Lin G, Su L, Xue L, Duan K, Chen L Heliyon. 2024; 10(8):e29357.

PMID: 38681550 PMC: 11053175. DOI: 10.1016/j.heliyon.2024.e29357.


Unraveling the Interplay of Dopamine, Carbon Monoxide, and Heme Oxygenase in Neuromodulation and Cognition.

Bauer N, Liu D, Nguyen T, Wang B ACS Chem Neurosci. 2024; 15(3):400-407.

PMID: 38214656 PMC: 10853931. DOI: 10.1021/acschemneuro.3c00742.


New insights into hypothalamic neurogenesis disruption after acute and intense stress: implications for microglia and inflammation.

Infantes-Lopez M, Nieto-Quero A, Chaves-Pena P, Zambrana-Infantes E, Cifuentes M, Marquez J Front Neurosci. 2023; 17:1190418.

PMID: 37425000 PMC: 10327603. DOI: 10.3389/fnins.2023.1190418.

References
1.
Codrich M, Bertuzzi M, Russo R, Francescatto M, Espinoza S, Zentilin L . Neuronal hemoglobin affects dopaminergic cells' response to stress. Cell Death Dis. 2017; 8(1):e2538. PMC: 5386368. DOI: 10.1038/cddis.2016.458. View

2.
Rodriguez Cruz Y, Strehaiano M, Rodriguez Obaya T, Garcia Rodriguez J, Maurice T . An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease. J Alzheimers Dis. 2016; 55(1):231-248. DOI: 10.3233/JAD-160500. View

3.
Altinoz M, Guloksuz S, Schmidt-Kastner R, Kenis G, Ince B, Rutten B . Involvement of hemoglobins in the pathophysiology of Alzheimer's disease. Exp Gerontol. 2019; 126:110680. DOI: 10.1016/j.exger.2019.110680. View

4.
Winner B, Jappelli R, Maji S, Desplats P, Boyer L, Aigner S . In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 2011; 108(10):4194-9. PMC: 3053976. DOI: 10.1073/pnas.1100976108. View

5.
Abd Elhadi S, Grigoletto J, Poli M, Arosio P, Arkadir D, Sharon R . α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls. Ann Clin Transl Neurol. 2019; 6(12):2426-2436. PMC: 6917335. DOI: 10.1002/acn3.50944. View